A $29 million judgment against Arthrex will stand in its patent war with KFx Medical after a federal judge in California declined to grant a new trial.
KFx Medical won a $29 million decision after a California jury found that orthopedics rival Arthrex infringed its patent covering technology used to attach soft tissue to bone.
KFx Medical won a pair of decisions in a patent infringement lawsuit against Arthrex over technology used to attach soft tissue to bone.
The latest turn in a nearly decade-long legal battle between Smith & Nephew (FTSE:SN, NYSE:SNN) and Arthrex over surgical anchor patents swung Smith & Nephew’s way yesterday, when the U.S. Court of Appeals for the Federal Circuit overturned a lower court’s ruling and sent the case back for reconsideration.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this holiday weekend, make sure you’re still in the know with MassDevice +7 and Happy Holidays from everyone at MassDevice!
Smith & Nephew (NYSE:SNN) saw its $85 million patent win against Arthrex Inc. overturned this week, after an Oregon judge ruled that Arthrex didn’t infringe on SNN’s surgical anchor patents.
The latest round in the 7-year-old patent lawsuit found that "no reasonable jury could possibly find that Arthrex infringed in this case," including via indirect infringement.
Smith & Nephew (NYSE:SNN) chalked up a $85 million win against Arthrex Inc. today, following a $4.7 million loss on Monday.
The jury in the U.S. District Court in Oregon found that Arthrex was guilty of patent infringement for the Naples, Fla.-based company’s SutureTak, PushLock and Bio-PushLock anchors used in shoulder repair.